The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORM.L Regulatory News (ORM)

  • There is currently no data for ORM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

27 Jun 2023 18:20

RNS Number : 1091E
Ormonde Mining PLC
27 June 2023
 

This announcement contains inside information

27 June 2023

 

Ormonde Mining plc

("Ormonde", the "Company" or the "Group")

 

Final Results for the Year Ended 31 December 2022

 

Ormonde announces its final results for the year ended 31 December 2022.

 

Key points:

 

· Sale of legacy La Zarza assets for €2.3 million, further strengthening the Group's balance sheet

· Investment in Peak Nickel Limited provides shareholders with exposure to fast-growing battery metals sector

· Extensive review of further natural resources projects has resulted in a shortlist of attractive possible further investments

· Applications have been made for the renewal of gold investigation permits in Spain

 

Brian Timmons, Chairman, commented:

 

"During 2022 and the first part of 2023, the Board has delivered on extracting value from legacy assets to boost the Group's balance sheet and commenced its proposed strategy of leveraging this strong balance sheet to generate new value enhancing deals for shareholders.

 

The sale of the La Zarza assets and subsequent investment into Peak Nickel Limited represent the first steps in shareholder value creation and provide the platform for further exciting investments in prospective mining jurisdictions. The Board continues to advance discussions with interested parties to move onto the next stages of this strategy.

 

On behalf of the Board, I would like to thank our shareholders for their continued support and especially for their patience displayed during the past 18 months. I look forward to updating you all on Ormonde's progress from here."

 

Enquiries:

 

Ormonde Mining plc

Brian Timmons, Chairman

Tel: +353 (0)1 801 4184

 

Vigo Consulting (Investor Relations)

Ben Simons / Charlie Neish

Tel: 44 (0)20 7390 0230

 

Davy (Nomad, Euronext Growth Listing Sponsor and Broker)

Anthony Farrell

Tel: +353 (0)1 679 6363

 

About Ormonde Mining plc

 

Ormonde is focussed on the evaluation and execution of new opportunities through which the Company can leverage its listing and balance sheet to generate shareholder value whilst placing a strong emphasis on cash preservation.

 

Currently, Ormonde holds a 20% interest in Peak Nickel Limited, a private UK company which is advancing exploration on a potentially significant battery metals project.

 

Ormonde's shares are listed on the London Stock Exchange (AIM) and the Euronext Growth market in Dublin.

 

For more information, visit the Company's website at www.ormondemining.com.

 

 

Chairman's Review

 

Introduction

I am pleased to present my second annual review to shareholders since I took over as Ormonde's Chairman in October 2021.

 

During the year, the Board, with the assistance of our technical advisory team, began delivering upon its commitment to leverage the Group's balance sheet to generate value for shareholders. This has involved an extensive review of a range of potential opportunities leading to a shortlist of attractive possible investments.

 

We are of course cognisant that shareholders have been waiting some time for news of further investments; however, this is a process that requires both time and diligence to ensure the transactions we pursue deliver the maximum opportunity for value creation. I would like to assure shareholders that discussions continue to progress, as does our partnership with our first investee company, Peak Nickel Limited.

 

The investment in Peak Nickel Limited announced in February 2023 provides Ormonde's shareholders with exposure to the fast growing and active battery metals sector. The Board expects further investments to follow.

 

This investment activity was undertaken whilst the Board worked to monetise the legacy La Zarza asset in Spain. Ormonde continues to seek value adding options for the Group's remaining Spanish gold assets.

 

Investment - Peak Nickel Limited

Subsequent to the year end, the Group acquired a 20% interest in Peak Nickel Limited ("PNL") for total payments of £512,500. PNL is a UK company which is advancing exploration on a very promising battery metals project. The Group's investment was designed to enable a fast-track initial drilling programme aimed at identifying a modern, code-compliant resource in those minerals.

 

At the time of investment, Ormonde was granted an exclusive option by PNL to either invest up to a further £4 million in cash in PNL for further exploration work, bringing Ormonde's interest to 49.9%; or acquire the remaining 80% of PNL by way of issuance of ordinary shares in Ormonde to PNL. 

 

La Zarza Disposal

While new opportunities with significant value upside potential were being shortlisted, the Board continued to advance negotiations with interested parties towards monetising the value within the legacy La Zarza Copper-Gold Project in Spain ("La Zarza"). 

 

On 28 September 2022, shareholders approved at an EGM a proposal from the Board for the sale of the Group's landholding, drill core and data assets associated with La Zarza for a cash consideration of €2.3 million to La Zarza Mineria Metalica S.L.U., a subsidiary of the Spanish company Tharsis Mining S.L., which controls the mining rights to La Zarza.

 

Under the terms of this sale agreement, the Group received the first tranche payment of €800,000 on closing, with the balance to be paid in three equal payments of €500,000 on the first, second and third anniversaries of completion. The next payment is due to be received on or around 30 September 2023, further boosting the Group's balance sheet. Ormonde holds security in respect of the deferred cash payments.

 

Spanish Assets

The Group's interest in a number of gold investigation permits (IPs) situated in Spain, held for over a decade, expired during the Covid period, and the Group has applied for renewal of these exploration licenses. In the event that these IPs are renewed, Ormonde intends to undertake exploration activity on the licences. There is no certainty of renewal of the IPs, and, accordingly, these assets have been subject to an impairment of €167,000 as at 31 December 2022.

 

Financials

Ormonde recorded a total comprehensive loss for the period of €1.1 million for 2022, compared with a loss of €1.6 million in 2021. As of 31 December 2022, the Group had net assets of €4.9 million, including a cash balance of €3.56 million, providing the Group with a platform from which to invest further.

 

Suspension of Shares

The Board is mindful of the continued suspended status of the Group's shares under market rules pending an announcement and publication of an admission document. As announced on 7 February 2023, following the PNL investment, Ormonde is required to execute a further transaction with PNL or another party, which would be categorised as a reverse takeover under AIM Rule 14. This transaction would require both shareholder approval and the publication of an AIM admission document. Ormonde continues to review its investment options in relation to this requirement and the Board looks forward to sharing its strategy with shareholders in due course.

 

Conclusions and Outlook

During 2022 and the first part of 2023, the Board has delivered on extracting value from legacy assets to boost the Group's balance sheet and commenced its proposed strategy of leveraging this strong balance sheet to generate new value enhancing deals for shareholders.

 

The sale of the La Zarza assets and subsequent investment into PNL represent the first steps in shareholder value creation and provide the platform for further exciting investments in prospective mining jurisdictions. The Board continues to advance discussions with interested parties to move onto the next stages of this strategy.

 

On behalf of the Board, I would like to thank our shareholders for their continued support and especially for their patience displayed during the past 18 months. I look forward to updating you all on Ormonde's progress in due course.

 

Brian Timmons

Chairman

27 June 2023

 

 

Consolidated Statement of Comprehensive Income

for the year ended 31 December 2022

 

 

Year ended

Year ended

 

31-Dec-22

31-Dec-21

 

Notes

€000s

€000s

 

Revenue

 

0

0

 

Administration expenses

(881)

(1,194)

Impairment of intangibles

10

(167)

(400)

______

______

Loss on ordinary activities

 

(1,048)

(1,594)

 

Finance costs

(17)

(24)

______

______

Loss for the year

 

(1,065)

(1,618)

 

Taxation

0

0

______

______

Loss for the Period after tax

 

(1,065)

(1,618)

 

______

______

Total comprehensive (loss)/income for the period

 

(1,065)

(1,618)

 

 

Earnings per share

 

Basic & diluted (loss) per share (in cent)

8

(0.23)

(0.34)

Total earnings per share

 

Basic & diluted earnings/ (loss) per share (in cent)

8

(0.23)

(0.34)

 

All activities are derived from continuing activities. All (losses)/profits and total comprehensive loss for the year (and preceding year) are attributable to the equity holders of the Company. The Group has not recognised gains or losses other than those dealt within the Statement of Comprehensive Income.

 

 

Consolidated Statement of Financial Position

as at 31 December 2022

 

31-Dec-22

31-Dec-21

 

Notes

€000s

€000s

Assets

 

Non-current assets

 

Intangible assets

10

157

309

Trade and other receivables

14

700

0

_______

_______

Total Non-Current Assets

 

857

309

 

Current assets

 

Trade and other receivables

14

613

93

Asset classified as held for sale

13

0

2,000

Cash & cash equivalents

15

3,564

3,746

_______

_______

Total Current Assets

 

4,177

5,839

_______

_______

Total Assets

 

5,034

6,148

 

_______

_______

Equity & liabilities

 

Capital and Reserves

 

Issued capital

17

4,725

4,725

Share premium account

17

29,932

29,932

Share based payment reserve

18

281

281

Capital conversion reserve fund

18

29

29

Capital redemption reserve fund

18

7

7

Retained losses

19

(30,078)

(29,013)

_______

_______

Equity attributable to the Owners of the Company

 

4,896

5,961

Current Liabilities

 

Trade & other payables

16

138

187

_______

_______

Total Liabilities

 

138

187

 

_______

_______

Total Equity & Liabilities

 

5,034

6,148

 

_______

_______

 

 

Company Statement of Financial Position

as at 31 December 2022

31-Dec-22

As regrouped

31-Dec-21

 

Notes

€000s

€000s

Assets

 

Investment in subsidiaries

12

130

443

Trade and other receivables

14

1,388

2,079

_______

_______

Total Non-Current Assets

 

1,518

2,522

 

Current assets

 

Trade and other receivables

14

95

76

Cash & cash equivalents

15

3,554

3,740

_______

_______

Total Current Assets

 

3,649

3,816

_______

_______

Total Assets

 

5,167

6,338

 

_______

_______

Equity & Liabilities

 

Capital and Reserves

 

Issued capital

17

4,725

4,725

Share premium account

17

29,932

29,932

Share based payment reserve

18

281

281

Capital conversion reserve fund

18

29

29

Capital redemption reserve fund

18

7

7

Retained losses

19

(30,051)

(28,935)

_______

_______

Equity attributable to the Owners of the Company

 

4,923

6,039

Current Liabilities

 

Trade & other payables

16

244

299

_______

_______

Total Liabilities

 

244

299

 

_______

_______

Total Equity & Liabilities

 

5,167

6,338

 

_______

_______

 

 

Consolidated Statement of Cashflows

for the year ended 31 December 2022

 

Year ended

Year ended

 

Notes

31-Dec-22

31-Dec-21

 

€000s

€000s

 

Cashflows from operating activities

 

Loss for the year before taxation

(1,065)

(1,618)

________

________

 

(1,065)

(1,618)

Adjustments for:

 

Impairment of intangible assets

167

0

Impairment of Asset classified as held for resale

0

400

Non-cash items: Share Option cost

0

72

________

________

 

(898)

(1,146)

Movement in Working Capital

 

Movement in receivables

(20)

(35)

Movement in liabilities

(49)

(24)

________

________

Net Cash used in operations

 

(967)

(1,205)

 

Investing activities

 

Expenditure on intangible assets

(15)

(14)

Proceeds from disposal of assets held for resale

800

0

________

________

Net cash used in investing activities

 

785

(14)

 

Net (decrease) in cash and cash equivalents

 

(182)

(1,219)

 

Cash and cash equivalents at the beginning of the year

15

3,746

4,965

 

______

______

Cash and cash equivalents at the end of the year

15

3,564

3,746

 

______

______

 

 

The accompanying notes in the Annual Report and Group Financial Statements mailed to shareholders and available on the Group's website form an integral part of these financial statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR UBVNRORUNUAR
Date   Source Headline
5th Sep 20237:00 amRNSTrading on Aquis Growth Market
5th Sep 20237:00 amRNSCancellation - ORMONDE MINING PLC
4th Sep 20238:28 amRNSAdmission to Aquis Growth Market
25th Aug 20233:33 pmRNSResult of EGM & AGM
31st Jul 20236:26 pmRNSNotice of EGM & AGM
27th Jul 20236:19 pmRNSProposed Cancellation of Trading on AIM & Euronext
30th Jun 20236:27 pmRNSInvestment in TRU Precious Metals Corp.
27th Jun 20236:20 pmRNSFinal Results
8th Feb 20236:00 pmRNSOrmonde Mining
7th Feb 20237:30 amRNSSuspension - Ormonde Mining plc
7th Feb 20237:00 amRNSInvestment & Suspension of Listing
13th Jan 20234:40 pmRNSSecond Price Monitoring Extn
13th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Oct 202211:11 amRNSCompletion of Sale of La Zarza Assets
28th Sep 20221:15 pmRNSResult of AGM & EGM
28th Sep 20227:00 amRNSHalf-year Report
30th Aug 20223:24 pmRNSPublication of EGM Circular
29th Jul 20227:00 amRNSSale of La Zarza & Notice of EGM
27th Jun 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
21st Jun 20227:00 amRNSFinal Results
24th Dec 20211:19 pmRNSHolding(s) in Company
30th Nov 20217:00 amRNSAppointment of CEO
19th Nov 20217:00 amRNSGrant of Options
4th Oct 20217:00 amRNSBoard Roles and Disclosures for New Directors
30th Sep 20213:29 pmRNSResult of AGM
23rd Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSAGM Update
14th Jul 20217:00 amRNSAdjourned AGM
1st Jul 20214:40 pmRNSSecond Price Monitoring Extn
1st Jul 20214:35 pmRNSPrice Monitoring Extension
1st Jul 20212:05 pmRNSSecond Price Monitoring Extn
1st Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20219:50 amRNSAGM Update
29th Jun 20217:00 amRNSAGM - Director Requisitions
24th Jun 20214:40 pmRNSSecond Price Monitoring Extn
24th Jun 20214:35 pmRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSAnnual Report & Notice of AGM
26th May 20217:00 amRNSHolding(s) in Company
26th May 20217:00 amRNSFinal Results
7th Apr 20219:05 amRNSSecond Price Monitoring Extn
7th Apr 20219:00 amRNSPrice Monitoring Extension
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20212:43 pmRNSUpdate on Acquisition
23rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
12th Mar 20215:00 pmRNSUpdate on Migration
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.